Literature DB >> 8562492

Variability in BPRS definitions of positive and negative symptoms.

I R Nicholson1, J E Chapman, R W Neufeld.   

Abstract

Reviewing Brief Psychiatric Rating Scale (BPRS) research indicates that combining items to form larger 'symptom factors' (e.g., depression, psychosis) has become the standard methodology. Unfortunately, a single symptom factor may be defined by different combinations of different BPRS items in different studies. To examine the potential impact of these differences, a number of different BPRS definitions of positive and negative symptoms in schizophrenia were culled from previous research. To compare these definitions, one hundred schizophrenics were interviewed with regard to current and recent symptomatology and rated on the BPRS, the Schedule for the Assessment of Negative Symptoms (SANS), and the Schedule for the Assessment of Positive Symptoms (SAPS). The four BPRS negative symptom definitions all correlated highly with one another and with the SANS. There were no differences in the amount that these different definitions of negative symptoms correlated with the SANS. Also, the nine definitions of positive symptoms all correlated highly with one another and with the SAPS. However, there were significant differences in how they correlated with the SAPS. Because of these differences, possible standard definitions for negative and positive symptoms of schizophrenia are proposed for future use of the BPRS in research.

Entities:  

Mesh:

Year:  1995        PMID: 8562492     DOI: 10.1016/0920-9964(94)00088-p

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Delayed preattentional functioning in early psychosis patients with cannabis use.

Authors:  Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2012-03-09       Impact factor: 4.530

2.  How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials.

Authors:  Myrto T Samara; Adriani Nikolakopoulou; Georgia Salanti; Stefan Leucht
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

Review 3.  Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Authors:  Noah L Lazar; Richard W J Neufeld; Donald P Cain
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

4.  Evaluating delay of gamma oscillations in patients with schizophrenia using evoked response audiometry system.

Authors:  Masaya Yanagi; Aki Tsuchiya; Fumiharu Hosomi; Toru Terada; Satoshi Ozaki; Osamu Shirakawa; Mamoru Hashimoto
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

5.  Schizophrenia patients show deficits in shifts of attention to different levels of global-local stimuli: evidence for magnocellular dysfunction.

Authors:  Michael J Coleman; Laurie Cestnick; Olga Krastoshevsky; Verena Krause; Zhuying Huang; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Bull       Date:  2009-09-08       Impact factor: 9.306

6.  Initial and Progressive Gray Matter Abnormalities in Insular Gyrus and Temporal Pole in First-Episode Schizophrenia Contrasted With First-Episode Affective Psychosis.

Authors:  Sang-Hyuk Lee; Margaret Niznikiewicz; Takeshi Asami; Tatsui Otsuka; Dean F Salisbury; Martha E Shenton; Robert W McCarley
Journal:  Schizophr Bull       Date:  2015-12-16       Impact factor: 9.306

7.  Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach.

Authors:  Maude Schneider; Marie Schaer; A Kadir Mutlu; Sarah Menghetti; Bronwyn Glaser; Martin Debbané; Stephan Eliez
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-09-03       Impact factor: 4.785

8.  Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Katherine Beck; Guy Hindley; Faith Borgan; Cedric Ginestet; Robert McCutcheon; Stefan Brugger; Naomi Driesen; Mohini Ranganathan; Deepak Cyril D'Souza; Matthew Taylor; John H Krystal; Oliver D Howes
Journal:  JAMA Netw Open       Date:  2020-05-01

Review 9.  The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.

Authors:  Barbara J Sahakian; Annette B Bruhl; Jennifer Cook; Clare Killikelly; George Savulich; Thomas Piercy; Sepehr Hafizi; Jesus Perez; Emilio Fernandez-Egea; John Suckling; Peter B Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

10.  Testing the psychometric properties of a Chinese version of the level of expressed emotion scale.

Authors:  Wai Tong Chien; Zenobia Chung-Yee Chan; Sally Wai-Chi Chan
Journal:  ScientificWorldJournal       Date:  2014-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.